We are working successfully to fight the depression epidemic in Africa.
We'll do the same in America.
Depression is a global challenge that requires a global solution. Our experience treating depression on one continent has positioned us to meet the needs of people on another.
Innovative Model = Uncommon Impact
Our innovative group therapy is considered one of the world's most effective models for reducing depression symptoms and preventing recurrence. The World Health Organization recommends our model as a first line treatment for depression.
Depression Reduction80% of participants are depression free or have minimal depression symptoms at the conclusion of group sessions & that result is sustained six months after therapy.
|
Increased Social- Emotional SupportsParticipants in our group therapy bond with one another. Many report they now have someone to turn to for support. 28% report feeling more connected to others.
|
Increased Participation in Work & School30% of participants report an increase in their children's school attendance & 16% report an increase in work attendance.
|
Treating Depression at Scale
StrongMinds AfricaVertical Divider
Since 2013, StrongMinds has provided group counseling to communities in Uganda and Zambia with the following results:
|
StrongMinds AmericaBeginning in late 2022, StrongMinds has delivered group therapy to youth (16-25) in communities across Northern New Jersey with the following anticipated results:
|
Program Evaluation
As a data-driven organization, StrongMinds America collects and analyzes participant data at multiple time points to quantify the impact and outcomes of our therapy. We use the Patient Health Questionnaire (PHQ-9) to measure and quantify depression in our participants. The PHQ-9 is administered at the initial screening, during a one-on-one pre-therapy session with a facilitator, halfway through the program (midline), and after the program’s final session (endline).
Participation (attendance rates) and participant-reported satisfaction are also tracked, as well as qualitative data, including participant and group leader interviews to understand engagement, preferences, group dynamics, and additional reported outcomes. We utilize external enumerators to collect two-week and six-month post-therapy data for a representative sample of patients to prevent social desirability biases and ensure data integrity.
We work with independent research consultants/academic investigators to explore statistically significant results.
Participation (attendance rates) and participant-reported satisfaction are also tracked, as well as qualitative data, including participant and group leader interviews to understand engagement, preferences, group dynamics, and additional reported outcomes. We utilize external enumerators to collect two-week and six-month post-therapy data for a representative sample of patients to prevent social desirability biases and ensure data integrity.
We work with independent research consultants/academic investigators to explore statistically significant results.